Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Toto is Professor of Medicine and Director of Clinical Nephrology and Patient-Oriented Research at The University of Texas Southwestern Medical Center, Dallas, Texas. He is nationally and internationally known for his clinical research, teaching, and organizational skills. He is deeply involved in training programs in patient-oriented research, particularly in chronic kidney disease (CKD). Dr Toto's research interests include detection, prevention and treatment of common progressive kidney diseases such as diabetes and hypertension. As well as conducting research in this area, he has extensive experience in the care and management of patients with these diseases. In addition, he is interested in mechanisms of dyslipidemia and hypertension in patients with CKD. Dr Toto has been a principal investigator in major clinical trials of CKD prevention, including the African-American Study of Kidney Disease (AASK trial), the HEMO study and the RENAAL trial.
Rhian M. Touyz
Dr Touyz is the Canada Research Chair in Hypertension at the Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa. She is Professor of Medicine at the University of Ottawa and works as a clinician in the Division of Nephrology. Dr Touyz received her medical training and degrees from the University of the Wiwatersrand, Johannesburg, South Africa, and completed post-doctoral training at the Clinical Research Institute of Montreal, Canada. She has received numerous academic and research awards, including the Young Investigator Awards from the American Society of Hypertension, Canadian Society of Hypertension, the Quebec Society of Hypertension and the Goldie Goldsmith research award from the American College of Nutrition, and was also a finalist for the Irving H Page Award, Atherosclerosis Thrombosis and Vascular Biology from the American Heart Association (AHA). She was awarded the 2005 Dahl Lecture Award by the AHA, in recognition of her contributions to hypertension research.
Dr Touyz is on the executive of the Canadian Hypertension Education Program (CHEP) and co-chairs its Recommendations Task Force. She is funded by grants from the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research, and is a member of the cardiovascular committees in both agencies. In addition, she is on the editorial board of Hypertension, Journal of Hypertension, American Journal of Physiology, Magnesium, Current Hypertension Reviews, Circulation Research, Current Opinion in Nephrology and Hypertension, and is Associate Editor of Clinical Science and the Journal of the American Society of Hypertension. Dr Touyz has published over 190 original papers, reviews and book chapters. Her areas of research include clinical and experimental hypertension, hypertension in renal disease, signal transduction, oxidative stress, ion transport, vascular remodeling and insulin resistance and diabetes. She has a particular interest in translational research.